News

New Nomograms Predict Lymphedema After Axillary Lymph Node Dissection

Publish date: September 7, 2011

 

FROM A BREAST CANCER SYMPOSIUM SPONSORED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Dr. Bevilacqua reported that he had no relevant conflicts of interest.

Pages

Recommended Reading

Vemurafenib Will Open Floodgates for Melanoma Genotyping
MDedge Family Medicine
MULTIMEDIA: Vemurafenib -- Melanoma Drug Cuts Death Risk
MDedge Family Medicine
Uncertainty Rules Adjuvant Chemo for Early HER2 Breast Cancer
MDedge Family Medicine
Smoking-Bladder Cancer Link Strengthened - Especially in Women
MDedge Family Medicine
FDA Approves Vemurafenib for Advanced Melanoma
MDedge Family Medicine
ATHENA: HPV Testing Outperforms Cytology for Cervical Cancer Screening
MDedge Family Medicine
Crizotinib Approval Personalizes Lung Cancer Therapy
MDedge Family Medicine
Study Supports Palpation, Mammography Regardless of Age
MDedge Family Medicine
PSA screening isn’t “nonsense”—it saved my life
MDedge Family Medicine
The mammography controversy: When should you screen?
MDedge Family Medicine